ANDREW G MAYER

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology LA JOLLA, CA NPI 1215949201

General Payments — all program years on this page

$2,831.68

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 168
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $466.04 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.0422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $758.4448
2019 $589.8234
2020 $51.713
2021 $278.3517
2022 $336.9321
2023 $350.3923
2024 $466.0422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075855055 Celltrion USA Inc. $15.15 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078301614 Janssen Biotech, Inc. $16.82 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078302690 Janssen Biotech, Inc. $27.07 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078302786 Janssen Biotech, Inc. $19.92 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988620 ABBVIE INC. $16.46 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988622 ABBVIE INC. $4.27 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988624 ABBVIE INC. $13.01 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988626 ABBVIE INC. $23.92 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988628 ABBVIE INC. $17.91 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988630 ABBVIE INC. $7.89 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988632 ABBVIE INC. $16.08 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988634 ABBVIE INC. $25.21 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988636 ABBVIE INC. $30.55 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988638 ABBVIE INC. $13.55 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988640 ABBVIE INC. $18.92 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988642 ABBVIE INC. $32.51 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988644 ABBVIE INC. $14.66 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988646 ABBVIE INC. $21.07 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104988648 ABBVIE INC. $27.56 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113630558 Intercept Pharmaceuticals, Inc. $29.69 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137631711 Takeda Pharmaceuticals U.S.A., Inc. $26.20 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154307892 CapsoVision, Inc. $47.62 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.